Acad Emerg Med

1. LONG B, Gottlieb M
   Higher-Dose Versus Standard-Dose Prophylactic Anticoagulation in Hospitalized Patients with COVID-19.
   Acad Emerg Med. 2021 Nov 15. doi: 10.1111/acem.14417.
   

   >> Share

   
   

   
   Am J Obstet Gynecol

2. ETTI M, Calvert A, Galiza E, Lim S, et al
   Maternal vaccination: A review of current evidence and recommendations.
   Am J Obstet Gynecol. 2021 Nov 11. pii: S0002-9378(21)01228.
   

   >> Share

   
   
3. CHERVENAK FA, McCullough LB, Grunebaum A
   Reversing Physician Hesitancy to Recommend COVID-19 Vaccination for Pregnant Patients.
   Am J Obstet Gynecol. 2021 Nov 8. pii: S0002-9378(21)01210.
   

   >> Share

   
   
4. OAKLEY LL, Ortqvist AK, Kinge J, Hansen AV, et al
   Preterm birth after the introduction of COVID-19 mitigation measures in Norway, Sweden and Denmark: a registry-based difference-in-differences study.
   Am J Obstet Gynecol. 2021 Nov 11. pii: S0002-9378(21)01231.
   

   >> Share

   
   

   
   Am J Respir Crit Care Med

5. O'NEIL ER, Lin H, Shamshirsaz AA, Naoum EE, et al
   Pregnant/Peripartum Women with COVID-19 High Survival with ECMO: An ELSO Registry Analysis.
   Am J Respir Crit Care Med. 2021 Nov 12. doi: 10.1164/rccm.202109-2096.
   

   >> Share

   
   
6. GRIECO DL, Menga LS, Cesarano M, Spadaro S, et al
   Phenotypes of COVID-19 Patients with Positive Clinical Response to Helmet Noninvasive Ventilation.
   Am J Respir Crit Care Med. 2021 Nov 17. doi: 10.1164/rccm.202105-1212.
   

   >> Share

   
   

   
   Ann Intern Med

7. DELGADO MK, Morgan AU, Asch DA, Xiong R, et al
   Comparative Effectiveness of an Automated Text Messaging Service for Monitoring COVID-19 at Home.
   Ann Intern Med. 2021 Nov 16. doi: 10.7326/M21-2019.
   

   >> Share

   
   
8. DORFMAN AL, Murthy VL
   Web Exclusive. Annals for Hospitalists Inpatient Notes - Myocarditis After Vaccination for SARS-CoV-2.
   Ann Intern Med. 2021;174:HO2-HO3.
   

   >> Share

   
   
9. FARO JM, Cutrona SL
   Extending a Lifeline to Nonhospitalized Patients With COVID-19 Through Automated Text Messaging.
   Ann Intern Med. 2021 Nov 16. doi: 10.7326/M21-4273.
   

   >> Share

   
   
10. CHOU R, Dana T, Buckley DI, Selph S, et al
    Update Alert 10: Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers.
    Ann Intern Med. 2021 Nov 16. doi: 10.7326/M21-4294.
    

    >> Share

    
    

    
    Antiviral Res

11. SVILENOV HL, Sacherl J, Reiter A, Wolff LS, et al
    Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein.
    Antiviral Res. 2021 Nov 10:105197. doi: 10.1016/j.antiviral.2021.105197.
    

    >> Share

    
    
12. QIU H, Yuan XY, Cabral T, Manguiat K, et al
    Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies.
    Antiviral Res. 2021 Nov 8:105206. doi: 10.1016/j.antiviral.2021.105206.
    

    >> Share

    
    

    
    BMJ

13. VAN SCHALKWYK JM
    New Zealand's covid-19 policy switch will harm vulnerable people.
    BMJ. 2021;375:n2738.
    

    >> Share

    
    
14. DEVNANI M
    Overdiagnosis and overtreatment during the covid-19 pandemic.
    BMJ. 2021;375:n2688.
    

    >> Share

    
    
15. IACOBUCCI G
    Covid-19: BMA asks doctors to submit evidence on UK's pandemic response.
    BMJ. 2021;375:n2739.
    

    >> Share

    
    
16. LIMB M
    Covid-19: Pandemic reduced life expectancy in most developed countries, study finds.
    BMJ. 2021;375:n2750.
    

    >> Share

    
    
17. WISE J
    Covid-19: Pfizer vaccine provides 90% protection against infection in children aged 5-11, study finds.
    BMJ. 2021;375:n2746.
    

    >> Share

    
    
18. DYER O
    Covid-19: Singaporeans who remain "unvaccinated by choice" must fund own treatment, says government.
    BMJ. 2021;375:n2748.
    

    >> Share

    
    
19. KLEEFSTRA S, Leistikow I
    Turning patient engagement into the "new normal".
    BMJ. 2021;375:n2695.
    

    >> Share

    
    
20. VAN SCHALKWYK JM
    Buyer beware: molnupiravir may damage DNA.
    BMJ. 2021;375:n2663.
    

    >> Share

    
    
21. DYER O
    Covid-19: Moderna seeks to exclude US government scientists from vaccine patents, despite public investment.
    BMJ. 2021;375:n2781.
    

    >> Share

    
    
22. STAFFORD N
    Covid-19: Germany's doctors call for clear rules to "break chains of infection" as cases soar.
    BMJ. 2021;375:n2783.
    

    >> Share

    
    
23. IACOBUCCI G
    Covid-19: Hospitals move to create extra bed capacity to relieve pressure.
    BMJ. 2021;375:n2775.
    

    >> Share

    
    
24. TAYLOR L
    Covid-19: Trial of experimental "covid cure" is among worst medical ethics violations in Brazil's history, says regulator.
    BMJ. 2021;375:n2819.
    

    >> Share

    
    
25. TAYLOR L
    Covid-19: Antimicrobial misuse in Americas sees drug resistant infections surge, says WHO.
    BMJ. 2021;375:n2845.
    

    >> Share

    
    
26. ALTMANN D, Boyton R
    Covid-19 caseload in the UK-assessments and mitigations.
    BMJ. 2021;375:n2843.
    

    >> Share

    
    
27. CAAN W
    Parliamentary committee report on covid-19 response: the difference between an apology and repentance.
    BMJ. 2021;375:n2813.
    

    >> Share

    
    
28. TANNE JH
    Covid 19: US government committee hears how social media spreads misinformation.
    BMJ. 2021;375:n2834.
    

    >> Share

    
    
29. GLASZIOU PP, Michie S, Fretheim A
    Public health measures for covid-19.
    BMJ. 2021;375:n2729.
    

    >> Share

    
    
30. IACOBUCCI G
    Covid-19: England is preparing to offer annual booster vaccination, says NHS boss.
    BMJ. 2021;375:n2824.
    

    >> Share

    
    
31. TALIC S, Shah S, Wild H, Gasevic D, et al
    Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis.
    BMJ. 2021;375:e068302.
    

    >> Share

    
    
32. WISE J
    Covid-19: Ten Conservative MPs and peers referred companies to "VIP lane" that won pound1.6bn of PPE contracts.
    BMJ. 2021;375:n2825.
    

    >> Share

    
    
33. MAHASE E
    Covid-19: Booster vaccine gives "significant increased protection" in over 50s.
    BMJ. 2021;375:n2814.
    

    >> Share

    
    
34. DYER O
    Covid-19: US doctor who called masks "dangerous" and vaccines a "human experiment" dies of coronavirus.
    BMJ. 2021;375:n2796.
    

    >> Share

    
    
35. DEVNANI M
    Covid-19 and laws for workplace violence in healthcare.
    BMJ. 2021;375:n2776.
    

    >> Share

    
    
36. BHUTTA ZA, Mitra A, Salman A, Akbari F, et al
    Conflict, extremism, resilience and peace in South Asia; can covid-19 provide a bridge for peace and rapprochement?
    BMJ. 2021;375:e067384.
    

    >> Share

    
    

    
    Br J Anaesth

37. HASLAM JD, Russell P, Hill S, Emmett SR, et al
    Chemical, biological, radiological, and nuclear mass casualty medicine: a review of lessons from the Salisbury and Amesbury Novichok nerve agent incidents.
    Br J Anaesth. 2021 Nov 15. pii: S0007-0912(21)00653.
    

    >> Share

    
    
38. FAZZINI B, Page A, Pearse R, Puthucheary Z, et al
    Prone positioning for non-intubated spontaneously breathing patients with acute hypoxaemic respiratory failure: a systematic review and meta-analysis.
    Br J Anaesth. 2021 Oct 14. pii: S0007-0912(21)00639.
    

    >> Share

    
    

    
    Clin Infect Dis

39. TEN DOESSCHATE T, Kuiper S, van Nieuwkoop C, Hassing RJ, et al
    Fosfomycin versus ciprofloxacin as oral stepdown treatment for Escherichia coli febrile urinary tract infection in women: a randomised, placebo-controlled, double blind, multicenter trial.
    Clin Infect Dis. 2021 Nov 16. pii: 6429720. doi: 10.1093.
    

    >> Share

    
    
40. LI ZJ, Yu LJ, Zhang HY, Shan CX, et al
    Broad impacts of COVID-19 pandemic on acute respiratory infections in China: an observational study.
    Clin Infect Dis. 2021 Nov 12. pii: 6426178. doi: 10.1093.
    

    >> Share

    
    
41. MADELON N, Lauper K, Breville G, Sabater Royo I, et al
    Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study.
    Clin Infect Dis. 2021 Nov 17. pii: 6430423. doi: 10.1093.
    

    >> Share

    
    
42. GILNER J, Kansal N, Biggio JR, Delaney S, et al
    Universal SARS-CoV-2 testing for obstetric inpatient units across the United States.
    Clin Infect Dis. 2021 Nov 17. pii: 6430425. doi: 10.1093.
    

    >> Share

    
    
43. HARRIS TG, Jaszi E, Lamb MR, Laudari CA, et al
    Effects of the COVID-19 Pandemic on HIV Services: Findings from 11 Sub-Saharan African Countries.
    Clin Infect Dis. 2021 Nov 15. pii: 6428385. doi: 10.1093.
    

    >> Share

    
    
44. LYNCH JB, Davitkov P, Anderson DJ, Bhimraj A, et al
    Infectious Diseases Society of America Guidelines on Infection Prevention for Healthcare Personnel Caring for Patients with Suspected or Known COVID-19.
    Clin Infect Dis. 2021 Nov 15. pii: 6428563. doi: 10.1093.
    

    >> Share

    
    
45. AKINBAMI LJ, Biggerstaff BJ, Chan PA, McGibbon E, et al
    Reinfection with SARS-CoV-2 among previously infected healthcare personnel and first responders.
    Clin Infect Dis. 2021 Nov 15. pii: 6428613. doi: 10.1093.
    

    >> Share

    
    
46. SHEN Z, Xiao Y, Kang L, Ma W, et al
    Corrigendum to: Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease 2019.
    Clin Infect Dis. 2021 Nov 13. pii: 6427503. doi: 10.1093.
    

    >> Share

    
    

    
    Emerg Infect Dis

47. GHARPURE R, Sami S, Vostok J, Johnson H, et al
    Multistate Outbreak of SARS-CoV-2 Infections, Including Vaccine Breakthrough Infections, Associated with Large Public Gatherings, United States.
    Emerg Infect Dis. 2021;28.
    

    >> Share

    
    

    
    Infect Control Hosp Epidemiol

48. NEILL C, Sartaj M, Holcroft L, Hasan SS, et al
    Surveillance study of asymptomatic and presymptomatic coronavirus disease 2019 (COVID-19) in care homes in Northern Ireland.
    Infect Control Hosp Epidemiol. 2021;42:1400-1402.
    

    >> Share

    
    
49. TURABELIDZE G, Faulconer BC, Lawrence SJ, Pierce A, et al
    Healthcare-associated outbreak of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in a rural hospital in Missouri, March 2020.
    Infect Control Hosp Epidemiol. 2021;42:1395-1396.
    

    >> Share

    
    
50. PALMORE TN, Henderson DK
    Healthcare-associated infections during the coronavirus disease 2019 (COVID-19) pandemic.
    Infect Control Hosp Epidemiol. 2021;42:1372-1373.
    

    >> Share

    
    
51. ZHANG HL, Kelly BJ, David MZ, Lautenbach E, et al
    SARS-CoV-2 surface contamination in staff common areas and impact on healthcare worker infection: prospective surveillance during the COVID-19 pandemic.
    Infect Control Hosp Epidemiol. 2021 Nov 15:1-10. doi: 10.1017/ice.2021.
    

    >> Share

    
    

    
    Int J Infect Dis

52. DOTAN A, Shoenfeld Y
    Post-COVID syndrome: the aftershock of SARS-CoV-2.
    Int J Infect Dis. 2021 Nov 13. pii: S1201-9712(21)00867.
    

    >> Share

    
    
53. ALI MM, Malik SMMR, Ahmed AY, Bashir AM, et al
    Survival analysis of all critically ill patients with COVID-19 admitted to the main hospital in Mogadishu, Somalia, 30 March-12 June 2020: what interventions are proving effective in fragile states?
    Int J Infect Dis. 2021 Nov 12. pii: S1201-9712(21)00865.
    

    >> Share

    
    
54. WEE LE, Conceicao EP, Sim JX, Venkatachalam I, et al
    Utilisation of SARS-CoV-2 rapid antigen assays in screening asymptomatic hospital visitors: mitigating the risk in low-incidence settings.
    Int J Infect Dis. 2021 Nov 9. pii: S1201-9712(21)00859.
    

    >> Share

    
    

    
    J Infect

55. BEN S, Xin J, Chen S, Jiang Y, et al
    Global internet search trends related to gastrointestinal symptoms predict regional COVID-19 outbreaks.
    J Infect. 2021 Nov 9. pii: S0163-4453(21)00546.
    

    >> Share

    
    
56. YAN X, Zhu S, Jin Z, Chen G, et al
    Persistence of anti-SARS-CoV-2 IgM in convalescent COVID-19 patients.
    J Infect. 2021 Nov 13. pii: S0163-4453(21)00550.
    

    >> Share

    
    
57. CHAPPELL H, Patel R, Driessens C, Tarr AW, et al
    Immunocompromised children and young people are at no increased risk of severe COVID-19.
    J Infect. 2021 Nov 13. pii: S0163-4453(21)00548.
    

    >> Share

    
    

    
    J Med Virol

58. RASHEDI R, Samieefar N, Masoumi N, Mohseni S, et al
    COVID-19 vaccines Mix-and-Match: The Concept, the Efficacy and the Doubts.
    J Med Virol. 2021 Nov 19. doi: 10.1002/jmv.27463.
    

    >> Share

    
    
59. BENJAMANUKUL S, Traiyan S, Yorsaeng R, Vichaiwattana P, et al
    Safety and immunogenicity of inactivated COVID-19 vaccine in health care workers.
    J Med Virol. 2021 Nov 15. doi: 10.1002/jmv.27458.
    

    >> Share

    
    
60. SONG J, Li C, Rivailler P, Wang H, et al
    Molecular evolution and genomic characteristics of genotype H1 of measles virus.
    J Med Virol. 2021 Nov 11. doi: 10.1002/jmv.27448.
    

    >> Share

    
    
61. OZGOCER T, Dagli SN, Ceylan MR, Disli F, et al
    Analysis of long-term antibody response in COVID-19 patients by symptoms grade, gender, age, BMI, and medication.
    J Med Virol. 2021 Nov 12. doi: 10.1002/jmv.27452.
    

    >> Share

    
    
62. ANGELETTI S, Giovanetti M, Fogolari M, Cella E, et al
    SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight.
    J Med Virol. 2021 Nov 12. doi: 10.1002/jmv.27451.
    

    >> Share

    
    
63. LIU K, Yang X, Feng C, Chen M, et al
    Clinical features and independent predictors for recurrence of positive SARS-CoV-2 RNA: A propensity score-matched analysis.
    J Med Virol. 2021 Nov 12. doi: 10.1002/jmv.27450.
    

    >> Share

    
    
64. SIVAN M, Parkin A, Makower S, Greenwood DC, et al
    Post-COVID Syndrome symptoms, functional disability and clinical severity phenotypes in hospitalised and non-hospitalised individuals: a cross-sectional evaluation from a community COVID rehabilitation service.
    J Med Virol. 2021 Nov 15. doi: 10.1002/jmv.27456.
    

    >> Share

    
    
65. CHANDAN S, Khan SR, Deliwala S, Mohan BP, et al
    Postvaccination SARS-CoV-2 infection among healthcare workers - A Systematic Review and meta-analysis.
    J Med Virol. 2021 Nov 15. doi: 10.1002/jmv.27457.
    

    >> Share

    
    
66. SINGH UB, Rophina M, Chaudhry R, Senthivel V, et al
    Variants of Concern responsible for SARS-CoV-2 vaccine breakthrough infections from India.
    J Med Virol. 2021 Nov 16. doi: 10.1002/jmv.27461.
    

    >> Share

    
    
67. VALIAN NK, Pourakbari B, Ashari KA, Sadeghi RH, et al
    Evaluation of human coronavirus OC43 and SARS-COV-2 in children with respiratory tract infection during the COVID-19 pandemic.
    J Med Virol. 2021 Nov 16. doi: 10.1002/jmv.27460.
    

    >> Share

    
    
68. GARCIA-SALGUERO C, Culebras E, Merino P, Baos E, et al
    Usefulness of SARS-CoV-2 Antigen Test Sample as input for SARS-CoV-2 RT-PCR analysis.
    J Med Virol. 2021 Nov 16. doi: 10.1002/jmv.27459.
    

    >> Share

    
    
69. FORERO-PENA DA, Carrion-Nessi FS, Mendoza-Millan DL, Omana-Avila OD, et al
    First wave of COVID-19 in Venezuela: Epidemiological, clinical, and paraclinical characteristics of first cases.
    J Med Virol. 2021 Nov 11. doi: 10.1002/jmv.27449.
    

    >> Share

    
    

    
    J Thorac Oncol

70. ROLFO C, Meshulami N, Russo A, Krammer F, et al
    Lung Cancer and SARS-CoV-2 infection: Identifying important knowledge gaps for investigation.
    J Thorac Oncol. 2021 Nov 10. pii: S1556-0864(21)03309.
    

    >> Share

    
    
71. GOUNANT V, Ferre VM, Soussi G, Charpentier C, et al
    Efficacy of SARS-CoV-2 vaccine in thoracic cancer patients: a prospective study supporting a third dose in patients with minimal serologic response after two vaccine doses.
    J Thorac Oncol. 2021 Nov 2. pii: S1556-0864(21)03286.
    

    >> Share

    
    

    
    J Travel Med

72. MOLERO-SALINAS A, Rico-Luna C, Losada C, Buenestado-Serrano S, et al
    High SARS-CoV-2 viral load in travellers arriving in Spain with a negative COVID-19 test prior to departure.
    J Travel Med. 2021 Nov 16. pii: 6428778. doi: 10.1093.
    

    >> Share

    
    

    
    J Virol

73. HEMSATH JR, Liaci AM, Rubin JD, Parrett BJ, et al
    Ex Vivo and In Vivo CD46 Receptor Utilization by Species D Human Adenovirus Serotype 26 (HAdV26).
    J Virol. 2021 Nov 17:JVI0082621. doi: 10.1128/JVI.00826.
    

    >> Share

    
    

    
    JAMA

74. SLOMSKI A
    Thousands of US Youths Cope With the Trauma of Losing Parents to COVID-19.
    JAMA. 2021 Nov 17. pii: 2786533. doi: 10.1001/jama.2021.20846.
    

    >> Share

    
    
75. CROWE EH
    The Taste of Hope.
    JAMA. 2021;326:1683-1684.
    

    >> Share

    
    

    
    Lancet

76. LLOYD-SHERLOCK P, Lasco G, McKee M, Perianayagam A, et al
    Does vaccine ageism amount to gerontocide?
    Lancet. 2021 Aug 11. pii: S0140-6736(21)01689.
    

    >> Share

    
    
77. LANE R
    Gagandeep Kang: helping to shape a healthier India.
    Lancet. 2021;398:947.
    

    >> Share

    
    
78. SINGH S, McNab C, Olson RM, Bristol N, et al
    How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic.
    Lancet. 2021 Nov 8. pii: S0140-6736(21)01897.
    

    >> Share

    
    
79. BHUYAN P, Medin J, da Silva HG, Yadavalli M, et al
    Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? - Authors' reply.
    Lancet. 2021;398:1801-1802.
    

    >> Share

    
    
80. PAVORD S, Scully M, Lester W, Makris M, et al
    Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine?
    Lancet. 2021;398:1801.
    

    >> Share

    
    
81. BHUTTA ZA, Salam RA, Gomber A, Lewis-Watts L, et al
    A century past the discovery of insulin: global progress and challenges for type 1 diabetes among children and adolescents in low-income and middle-income countries.
    Lancet. 2021;398:1837-1850.
    

    >> Share

    
    
82. LI JX, Zhu FC
    Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02014.
    

    >> Share

    
    
83. LAZARUS R, Baos S, Cappel-Porter H, Carson-Stevens A, et al
    Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02329.
    

    >> Share

    
    
84. OMER SB, Benjamin RM, Brewer NT, Buttenheim AM, et al
    Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.
    Lancet. 2021 Nov 15. pii: S0140-6736(21)02507.
    

    >> Share

    
    
85. ELLA R, Reddy S, Blackwelder W, Potdar V, et al
    Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02000.
    

    >> Share

    
    
86. AUCOTT JN, Rebman AW
    Long-haul COVID: heed the lessons from other infection-triggered illnesses.
    Lancet. 2021;397:967-968.
    

    >> Share

    
    
87. KATES J, Dawson L, Horn TH, Killelea A, et al
    Insurance coverage and financing landscape for HIV treatment and prevention in the USA.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00397.
    

    >> Share

    
    
88. MAYER KH, Nelson L, Hightow-Weidman L, Mimiaga MJ, et al
    The persistent and evolving HIV epidemic in American men who have sex with men.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00321.
    

    >> Share

    
    
89. THE LANCET
    Myanmar's democracy and health on life support.
    Lancet. 2021;397:1035.
    

    >> Share

    
    

    
    Lancet Infect Dis

90. BAGCCHI S
    Infectious diseases in Afghanistan: a dismal scenario.
    Lancet Infect Dis. 2021;21:1357.
    

    >> Share

    
    
91. KENYON G
    Australia's struggle with the delta variant.
    Lancet Infect Dis. 2021;21:1358.
    

    >> Share

    
    
92. AUTZEN B, Dineen K, Vaughan D
    Vaccinating children: fairness and childism.
    Lancet Infect Dis. 2021;21:1354-1355.
    

    >> Share

    
    
93. VACHARATHIT V, Aiewsakun P, Manopwisedjaroen S, Srisaowakarn C, et al
    CoronaVac induces lower neutralising activity against variants of concern than natural infection.
    Lancet Infect Dis. 2021;21:1352-1354.
    

    >> Share

    
    
94. NASA P, Azoulay E, Chakrabarti A, Divatia JV, et al
    Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method.
    Lancet Infect Dis. 2021 Nov 10. pii: S1473-3099(21)00626.
    

    >> Share

    
    
95. KOJIMA N, Klausner JD
    Protective immunity after recovery from SARS-CoV-2 infection.
    Lancet Infect Dis. 2021 Nov 8. pii: S1473-3099(21)00676.
    

    >> Share

    
    
96. KIRBY T
    Van-Mai Cao-Lormeau-putting Pacific Islands on the map.
    Lancet Infect Dis. 2021;21:1362.
    

    >> Share

    
    
97. CHU CY, Marais G, Opperman C, Doolabh D, et al
    Performance of saliva and mid-turbinate swabs for detection of the beta variant in South Africa.
    Lancet Infect Dis. 2021;21:1354.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

98. FRENCH G, Hulse M, Nguyen D, Sobotka K, et al
    Impact of Hospital Strain on Excess Deaths During the COVID-19 Pandemic - United States, July 2020-July 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1613-1616.
    

    >> Share

    
    
99. NALEWAY AL, Groom HC, Crawford PM, Salas SB, et al
    Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged >/=12 Years, by COVID-19 Vaccination Status - Oregon and Washington, July 4-September 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1608-1612.
    

    >> Share

    
    
100. CZEISLER ME, Barrett CE, Siegel KR, Weaver MD, et al
     Health Care Access and Use Among Adults with Diabetes During the COVID-19 Pandemic - United States, February-March 2021.
     MMWR Morb Mortal Wkly Rep. 2021;70:1597-1602.
     

     >> Share

     
     
101. FARRELL L, Almond CR, Porterfield DS, Mobley V, et al
     Automated Digital Notification of COVID-19 Diagnoses Through Text and Email Messaging - North Carolina, December 2020-January 2021.
     MMWR Morb Mortal Wkly Rep. 2021;70:1603-1607.
     

     >> Share

     
     

     
     N Engl J Med

102. SCHONBORN L, Thiele T, Kaderali L, Greinacher A, et al
     Decline in Pathogenic Antibodies over Time in VITT.
     N Engl J Med. 2021;385:1815-1816.
     

     >> Share

     
     
103. ZARYCHANSKI R, Lawler PR, Goligher E
     Therapeutic Anticoagulation with Heparin in Patients with Covid-19. Reply.
     N Engl J Med. 2021;385:2014.
     

     >> Share

     
     
104. FERNANDES TM, McGuire WC, Morris TA
     Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
     N Engl J Med. 2021;385:2013.
     

     >> Share

     
     
105. STERPETTI AV
     Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
     N Engl J Med. 2021;385:2013-2014.
     

     >> Share

     
     
106. RUBIN EJ, Baden LR, Mello MM, Morrissey S, et al
     Audio Interview: The Legal Basis for Covid-19 Restrictions and Mandates.
     N Engl J Med. 2021;385:e88.
     

     >> Share

     
     
107. ASKENASE PW
     Rare Skin Reactions after mRNA Vaccination, Similar to Jones-Mote Basophil Responses.
     N Engl J Med. 2021;385:1720-1721.
     

     >> Share

     
     

     
     Nature

108. GEBRE MS, Rauch S, Roth N, Yu J, et al
     Optimization of Non-Coding Regions for a Non-Modified mRNA COVID-19 Vaccine.
     Nature. 2021 Nov 18. pii: 10.1038/s41586-021-04231.
     

     >> Share

     
     
109. MALLAPATY S
     Europe's COVID death toll could rise by hundreds of thousands.
     Nature. 2021 Nov 18. pii: 10.1038/d41586-021-03455.
     

     >> Share

     
     
110. LEDFORD H
     Millions of helpline calls reveal how COVID affected mental health.
     Nature. 2021 Nov 17. pii: 10.1038/d41586-021-03454.
     

     >> Share

     
     
111. BRAZIL R
     Do childhood colds help the body respond to COVID?
     Nature. 2021 Nov 18. pii: 10.1038/d41586-021-03087.
     

     >> Share

     
     
112. BRULHART M, Klotzbucher V, Lalive R, Reich SK, et al
     Mental health concerns during the COVID-19 pandemic as revealed by helpline calls.
     Nature. 2021 Nov 17. pii: 10.1038/s41586-021-04099.
     

     >> Share

     
     
113. LEDFORD H
     COVID antiviral pills: what scientists still want to know.
     Nature. 2021;599:358-359.
     

     >> Share

     
     
114. FLEMING N
     How to get a job in vaccine development.
     Nature. 2021 Nov 10. pii: 10.1038/d41586-021-03057.
     

     >> Share

     
     
115. ELSE H
     Sleeplessness and anxiety: PhD supervisors on toll of COVID pandemic.
     Nature. 2021 Nov 11. pii: 10.1038/d41586-021-03374.
     

     >> Share

     
     
116. WOOLSTON C
     Scientists count the career costs of COVID.
     Nature. 2021;599:331-334.
     

     >> Share

     
     
117. XIAO K, Zhai J, Feng Y, Zhou N, et al
     Author Correction: Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins.
     Nature. 2021 Nov 11. pii: 10.1038/s41586-021-03838.
     

     >> Share

     
     
118. KOZLOV M
     How do people resist COVID infections? Hospital workers offer a hint.
     Nature. 2021 Nov 11. pii: 10.1038/d41586-021-03110.
     

     >> Share

     
     
119. LIU CH, Tsai AC
     Helpline data used to monitor population distress in a pandemic.
     Nature. 2021 Nov 17. pii: 10.1038/d41586-021-03038.
     

     >> Share

     
     
120. LEDNICKY JA, Tagliamonte MS, White SK, Elbadry MA, et al
     Independent infections of porcine deltacoronavirus among Haitian children.
     Nature. 2021 Nov 17. pii: 10.1038/s41586-021-04111.
     

     >> Share

     
     
121. BAKER N
     Coronapod: new hope from COVID antiviral drugs.
     Nature. 2021 Nov 12. pii: 10.1038/d41586-021-03441.
     

     >> Share

     
     

     
     Radiol Cardiothorac Imaging

122. WILSON H, Norris MD, Frosch O, Agarwal PP, et al
     Late Gadolinium Enhancement after COVID-19 Vaccination.
     Radiol Cardiothorac Imaging. 2021;3:e210199.
     

     >> Share

     
     

     
     Science

123. CHYBA CF, Cassel CK, Graham SL, Holdren JP, et al
     Create a COVID-19 commission.
     Science. 2021;374:932-935.
     

     >> Share

     
     
124. WOROBEY M
     Dissecting the early COVID-19 cases in Wuhan.
     Science. 2021 Nov 18:eabm4454.
     

     >> Share

     
     
125. JECKER NS
     Cash incentives, ethics, and COVID-19 vaccination.
     Science. 2021;374:819-820.
     

     >> Share

     
     
126. COUZIN-FRANKEL J
     Antiviral pills could change pandemic's course.
     Science. 2021;374:799-800.
     

     >> Share

     
     
127. THORP HH
     Self-inflicted wounds.
     Science. 2021;374:793.
     

     >> Share

     
     
128. PIETZNER M, Wheeler E, Carrasco-Zanini J, Cortes A, et al
     Mapping the proteo-genomic convergence of human diseases.
     Science. 2021;374:eabj1541.
     

     >> Share

     
     
129. GERBER JS, Offit PA
     COVID-19 vaccines for children.
     Science. 2021;374:913.
     

     >> Share

     
     

     
     Travel Med Infect Dis

130. CHIODINI J
     A new era for travel medicine education.
     Travel Med Infect Dis. 2021;44:102208.
     

     >> Share

     
     
131. SCORZA FA, Finsterer J
     Apparent onset of COVID-19 after onset of SARS-CoV-2 associated Guillain-Barre syndrome.
     Travel Med Infect Dis. 2021;44:102201.
     

     >> Share

     
     
132. YASHIO T, Murayama A, Kami M, Ozaki A, et al
     COVID-19 infection during the Olympic and Paralympic Games Tokyo 2020.
     Travel Med Infect Dis. 2021 Nov 13:102205. doi: 10.1016/j.tmaid.2021.102205.
     

     >> Share

     
     
133. MOURY PH, Gourinat AC, Riou O, Laumond S, et al
     Successful COVID-19 elimination after an alpha variant outbreak in a "safe travel zone".
     Travel Med Infect Dis. 2021;44:102202.
     

     >> Share

     
     
134. ZHONG Y, Wang K, Zhu Y, Lyu D, et al
     Ocular manifestations in COVID-19 patients: A systematic review and meta-analysis.
     Travel Med Infect Dis. 2021;44:102191.
     

     >> Share

     
     
135. RESTUCCIA D, Carrion-Nessi FS, Omana-Avila OD, Mendoza-Millan DL, et al
     Prevalence of undiagnosed HIV in Venezuelan patients with suspected COVID-19 during the first wave: A complex syndemic.
     Travel Med Infect Dis. 2021;44:102207.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share